report banner

News in English

PostNews: Press Release

PHI AB annual general meeting moved to 27 October 2023

The PHI AB board has decided to move the company’s annual general meeting from 12 October 2023 to 27 October 2023.
Learn more …
PostNews
Businesspeople brainstorming together with sticky notes in an of

BioStock: PHI links up with two regenerative medicine networks

BioStock contacted CEO Patrik Eschricht to learn more about the company’s future strategies in regenerative medicine and the pivot toward the clinical market.
Learn more …
PostNews: Press Release
ARM-ATMP-banner-web

PHI Strengthens Commitment to Regenerative Medicine through ARM and ATMP Sweden Membership

PHI becomes a member of the leading international advocacy organization Alliance for Regenerative Medicine (ARM) as well as the national ATMP Sweden network to advocate for QPI technology for standard cell quality control in regenerative medicine.
Learn more …
PostNews
BioStock: PHI charts a bold course to impact regenerative medicine

BioStock: PHI charts a bold course to impact regenerative medicine

BioStock contacted CEO Patrik Eschricht to delve into the year-end report’s highlights and shed light on the company’s vision and initiatives.
Learn more …
PostNews
righst issue of units 2022 banner

BioStock: The five best life science stocks of the first half-year

PHI is proud to be highlighted as one of the top 5 best-performing Swedish life science stocks in the first half of 2023.
Learn more …
PostNews: Press Release
Artistic image of molecularly imprinted polymers (MIP).

European Patent Office intends to grant PHI patent on synthetic antibodies

PHI AB announces today that the European Patent Office (EPO) intends to grant a patent on synthetic antibodies.
Learn more …
1234530